CLBCX
Price
$34.97
Change
+$0.21 (+0.60%)
Updated
Jan 17 closing price
Net Assets
240.18B
PRPHX
Price
$59.88
Change
+$0.19 (+0.32%)
Updated
Jan 17 closing price
Net Assets
3.92B
Ad is loading...

CLBCX vs PRPHX

Header iconCLBCX vs PRPHX Comparison
Open Charts CLBCX vs PRPHXBanner chart's image
American Funds American Balanced 529C
Price$34.97
Change+$0.21 (+0.60%)
VolumeN/A
Net Assets240.18B
Permanent Portfolio Permanent C
Price$59.88
Change+$0.19 (+0.32%)
VolumeN/A
Net Assets3.92B
CLBCX vs PRPHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CLBCX vs. PRPHX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBCX is a Buy and PRPHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CLBCX has more cash in the bank: 240B vs. PRPHX (3.92B). CLBCX pays higher dividends than PRPHX: CLBCX (1.52) vs PRPHX (0.00). CLBCX was incepted earlier than PRPHX: CLBCX (23 years) vs PRPHX (9 years). CLBCX is a more actively managed with annual turnover of: 171.00 vs. PRPHX (15.26). CLBCX has a lower initial minimum investment than PRPHX: CLBCX (250) vs PRPHX (1000). PRPHX annual gain was more profitable for investors over the last year : 23.37 vs. CLBCX (11.42). PRPHX return over 5 years is better than : 46.46 vs. CLBCX (26.62).
CLBCXPRPHXCLBCX / PRPHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years9 years-
Gain YTD1.8943.27758%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets240B3.92B6,118%
Annual Yield % from dividends1.520.00-
Returns for 1 year11.4223.3749%
Returns for 3 years11.2424.8945%
Returns for 5 years26.6246.4657%
Returns for 10 years56.78N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ROK286.605.64
+2.01%
Rockwell Automation
SANM82.970.41
+0.50%
Sanmina Corp
YMAB6.16-0.02
-0.32%
Y-mAbs Therapeutics
SABS3.53-0.03
-0.84%
SAB Biotherapeutics
ALEX17.55-0.16
-0.90%
Alexander & Baldwin